Alembic Pharma Panelav facility receives 4 observations

Alembic Pharmaceuticals announced that US Food and Drug Administration (USFDA) conducted an inspection at Alembic Pharmaceuticals General Oral Solid Formulation Facility located in Panelav (Gujarat).

The inspection conducted by the regulator took place from March 9 to 13, 2020. At the conclusion of the inspection, USFDA issued a form 483 with four procedural observations. The company assured that none of the observations are related to data integrity or are repetitive in nature. Additionally, it also stated to immediately take comprehensive and corrective action for addressing the observations, so as to maintain high quality standards needed to meet USFDA standards.

Alembic Pharmaceuticals Ltd is a multinational pharmaceutical company headquartered in Vadodara (Gujarat). It is involved in the manufacture of pharmaceutical products, pharmaceutical substances and intermediates.

On Monday, the stock of the company closed at Rs 545.40, down by 5.15 per cent or Rs 29.60 per share. The 52-week high is Rs 682.50 and 52-week low is Rs 435.10 on BSE.